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https://doi.org/10.1186/s40168-019-0666-xRESEARCH Open AccessCharacterization of the total and viable
bacterial and fungal communities
associated with the International Space
Station surfaces
Aleksandra Checinska Sielaff1,10†, Camilla Urbaniak1†, Ganesh Babu Malli Mohan1, Victor G. Stepanov2, Quyen Tran2,
Jason M. Wood1, Jeremiah Minich3, Daniel McDonald4, Teresa Mayer1, Rob Knight4,5,6, Fathi Karouia7,8,9,
George E. Fox2 and Kasthuri Venkateswaran1*Abstract
Background: The International Space Station (ISS) is a closed system inhabited by microorganisms originating from
life support systems, cargo, and crew that are exposed to unique selective pressures such as microgravity. To date,
mandatory microbial monitoring and observational studies of spacecraft and space stations have been conducted
by traditional culture methods, although it is known that many microbes cannot be cultured with standard techniques.
To fully appreciate the true number and diversity of microbes that survive in the ISS, molecular and culture-based
methods were used to assess microbial communities on ISS surfaces. Samples were taken at eight pre-defined locations
during three flight missions spanning 14 months and analyzed upon return to Earth.
Results: The cultivable bacterial and fungal population ranged from 104 to 109 CFU/m2 depending on location and
consisted of various bacterial (Actinobacteria, Firmicutes, and Proteobacteria) and fungal (Ascomycota and Basidiomycota)
phyla. Amplicon sequencing detected more bacterial phyla when compared to the culture-based analyses, but both
methods identified similar numbers of fungal phyla. Changes in bacterial and fungal load (by culture and qPCR) were
observed over time but not across locations. Bacterial community composition changed over time, but not across
locations, while fungal community remained the same between samplings and locations. There were no significant
differences in community composition and richness after propidium monoazide sample treatment, suggesting that the
analyzed DNA was extracted from intact/viable organisms. Moreover, approximately 46% of intact/viable bacteria and
40% of intact/viable fungi could be cultured.
Conclusions: The results reveal a diverse population of bacteria and fungi on ISS environmental surfaces that changed
over time but remained similar between locations. The dominant organisms are associated with the human microbiome
and may include opportunistic pathogens. This study provides the first comprehensive catalog of both total and intact/
viable bacteria and fungi found on surfaces in closed space systems and can be used to help develop safety measures
that meet NASA requirements for deep space human habitation. The results of this study can have significant impact on
our understanding of other confined built environments on the Earth such as clean rooms used in the pharmaceutical
and medical industries.
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The International Space Station (ISS) is the largest hu-
man space platform in low Earth orbit (~ 400 km
above Earth’s surface) and for the last 17 years it has
been continuously inhabited by an international
community of astronauts performing space research.
The ISS is a hermetically sealed closed system, sub-
jected to microgravity, radiation, elevated carbon diox-
ide, and the recirculation of air through HEPA filters
and is considered an “extreme environment” [1, 2]. Mi-
crobes are known to survive and even thrive in
extreme environments, and the microbes that are
present on the ISS may have existed since the incep-
tion of the ISS while others may be introduced each
time new astronauts or payloads arrive.
Since the beginning of the ISS, routine microbial moni-
toring of surfaces, air, and water has occurred using
culture-based techniques as per the National Aeronautics
and Space Administration’s (NASA) operations and
maintenance requirement procedures [3]. However,
culture-based analysis limits our understanding of the
diversity of microbes that grow and thrive on the ISS be-
cause only a small fraction of organisms in a given envir-
onment can be cultured under standard laboratory
conditions [4]. Molecular methods, such as quantitative
polymerase chain reaction (qPCR) and targeted amplicon
sequencing, which can identify and quantify both cultur-
able and unculturable organisms provide a more thorough
assessment of what is actually present and in what
amounts [5]. However, while it has been recently shown
as a proof of concept that PCR [6] and amplicon sequen-
cing can be performed on the ISS [7, 8], microbial moni-
toring of the ISS with molecular-based methods is not
routinely used because of the lack of simple, compact, and
reliable sample processing instruments onboard the ISS.
Once such devices are available, rapid, real-time microbial
detection, functional analysis are possible for the long dur-
ation missions, but baseline information about the ISS
environmental microbiome is still needed.
The importance of cataloging the ISS microbiome, which
consists of both culturable and unculturable microbes, par-
allels the surge in research into the “built microbiome” here
on Earth. Emerging studies on the microbiome of homes
[9–11], offices, classrooms, museums [12, 13], and hospitals
[5, 14, 15] have revealed an assemblage of bacteria, fungi,
viruses, and protozoa unique to that indoor environment
that are influenced by a variety of factors such as building
design, ventilation, humidity, air pressure and flow, occu-
pant numbers, or activities performed [16, 17]. Specific mi-
crobes in these indoor spaces have been shown to impact
human health by influencing our susceptibility to allergies,
infectious diseases, or sick building syndrome [18]. The
influence of the indoor microbiome on human health be-
comes more important for astronauts during flights due toaltered immunity associated with space flight [19, 20] and
the lack of sophisticated medical interventions that are
available on Earth.
In light of an upcoming new era of human expansion
in the universe, such as future space travel to Mars, the
microbiome of the closed space environment needs to
be examined thoroughly to identify the types of microor-
ganisms that can accumulate in this unique environ-
ment, how long they persist and survive, and their
impact on human health and spacecraft infrastructure.
For this reason, the National Research Council (NRC)
Decadal Survey recommended that NASA establish a
coordinated, large-scale Microbial Observatory program
within the ISS platform [21]. As part of this NASA initia-
tive, the microbial communities on ISS surfaces from eight
defined locations over three flight missions, spanning
14 months, were characterized using culture-based tech-
niques, qPCR, and amplicon sequencing of the 16S rRNA
gene and internal transcribed spacer (ITS) region. Before
DNA extraction, half of the sample was treated with propi-
dium monoazide (PMA) so that the microbiome of intact/
viable cells (PMA treatment) could be characterized. The
PMA-untreated samples yielded information about the
total microbial population (including free DNA, dead cells,
cells with a compromised cell membrane, intact cells, and
viable cells). PMA binds to DNA, making the DNA un-
available for amplification during PCR steps [22]. Due to
its higher molecular weight and/or charge, PMA cannot
penetrate into cells that have an intact cell membrane (i.e.,
viable) but can bind to free floating DNA or DNA inside
cells with a compromised cell membrane (i.e., dead cells)
[22, 23]. It is in this way that many studies have utilized
PMA to distinguish between intact/viable cells and com-
promised/dead cells [2, 24–26].
This comprehensive analysis of the ISS microbiome
was used to assess how microbial communities change
over time (temporal distribution) and throughout the
ISS (spatial distribution). In addition, the ISS environ-
mental microbiome data were compared with other
Earth built environmental microbiome data such as the
Earth Microbiome Project [27], Hospital ([28], Qiita
study 10,172), and Office microbiome ([28], Qiita study
10,423). The implementation of novel molecular tech-
niques to monitor intact microbial populations in this
unique environment opens a possibility for broadening
the current surveillance practices to maintain the health
of the crew and to promote advances in deep space hu-
man habitation in the future.
Results
Twenty-four surface wipes were collected from eight
locations across the ISS during three flight missions over
the course of 14 months. In addition to these 24 wipes,
wipes that were taken out of the kits and exposed to the
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nated as controls and processed in parallel with the sam-
ple wipes. A summary of the sampled locations and the
associated metadata is presented in Fig. 1 and Table 1.
Cultivable microbial population
The cultivable microbial load from all flight samples and
their distribution patterns at various locations are
depicted. The average number of bacteria cultured on
blood agar (BA) and R2A plates was similar between F1
and F2 but higher at F3 (though this trend was notA
B
Fig. 1 Illustration of the eight locations sampled on the ISS over three flight sam
nodes and modules. The red arrows point to locations sampled during this stud
blue lines. Location #1, port panel next to cupola (Node 3); location #2, waste an
device (ARED) foot platform (node 3); location #4, dining table (node 1); location
module (PMM) port 1 (PMM); location #7, panel near portable water dispenser (
(node 2)statistically significant) (Fig. 2a). There were no statistically
significant differences in the average bacterial load across
the eight locations (Fig. 2b); however, the locations that
exceeded 1010 CFU/m2 during at least one flight sampling
event were L1 (port panel next to cupola), L5 (overhead
4), L7 (lab 3 overhead), and L8 (crew quarters), with the
lowest counts (less than 104 CFU/m2 in at least one sam-
pling event) found at L3 (AREM) and L6 (PMM). Overall,
the number of bacteria (combination of R2A and BA
growth) isolated from the ISS from all 24 samples ranged
from 6.7 × 103 to 7.8 × 1010 CFU/m2.pling sessions. a Schematic of the US module of the ISS depicting various
y. b Detailed images of the sampled area at each location as outlined by
d hygiene compartment (node 3); location #3, advanced resistive exercise
#5, zero G stowage rack (node 1); location #6, permanent multipurpose
LAB); and location #8, port crew quarters, bump out exterior aft wall
Table 1 Description of ISS locations and associated metadata, from which surface swabs were collected
Location number Location description ISS module
1 Port panel next to cupola Node 3
2 Waste and hygiene compartment Node 3 “F4”
3 Advanced resistive exercise device (ARED) foot platform Node 3
4 Dining table Node 1
5 Overhead 4 Node 1
6 Permanent multipurpose module (PMM) Port 1 PMM
7 Lab 3 overhead LAB
8 Port crew quarters, bump out exterior aft wall Node 2
Environmental parameters Flight 1 (F1) Flight 2 (F2) Flight3 (F3)
Sampling date March 4th 2015 May 15th 2015 May 6th 2016
Vehicle (ascent/descent) SpX-5/TMA-14A SpX-6/SpX-6 SpX-8/SpX-8
Crewmember who performed sampling T. Virts T. Virts J.Williams
Nodes are US modules that connect the elements of the ISS
Node 1, called Unity, was the first US-built element that was launched and connects the US and Russian Segments. Node 1 has 6 ports that provide berthing
connections to other modules, ISS infrastructure, and visiting cargo. The module has 4 racks. Some of which are used for stowage to return the cargo back to
Earth (ISS_5). Additionally, the dining table (ISS_4) is also located in Node 1
Node 2, called Harmony, connects the US, European, and Japanese laboratories. The module provides docking and berthing ports for Japanese and US vehicles.
Node 2 provides crew quarters (ISS_8) for 4 crew members as well as vital functional resources for the operation of the connected elements
Node 3, called Tranquility, is attached to the port side of Node 1 and provides accommodation for life support and exercise equipment. The cupola (ISS_1) is
berthed on its nadir (Earth facing) port and provides through multiple windows observation of operations outside the ISS such as robotic activities, the approach
of visiting vehicles, and extravehicular activities. Additionally, Node 3 accommodates critical equipment, air revitalization, oxygen, carbon dioxide removal, water
recovery system, the waste and hygienic compartment (bathroom; ISS_2), and exercising equipment such as a treadmill (ARED) and a weight-lifting device (ISS_3)
The US laboratory module, called Destiny, is the primary research facility for US payloads. The module hosts 24 equipment racks for accommodation and control
of ISS systems and scientific research in physical and biological sciences (ISS_7)
The Permanent Multipurpose Module, called PMM, hosts up to 16 stowage racks (ISS_6) containing equipment, experiments, and supplies, and its additional
storage space for bags in the aft endcone
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1.1 × 105 to 3.1 × 108 CFU/m2. While, there were no
statistically significant differences in fungal load over
time, the highest average was found during F1 and the
lowest at F2 (Fig. 2a). Similar to what was observed with
bacterial counts, no differences in fungal counts were
evident across the eight locations (Fig. 2b). When com-
pared to bacteria, the fungal population was lower by 2
to 3 logs at all locations except at L6 where fungal load
was 100-fold more than bacterial load (Fig. 2b). Due to
the high variability between samples, there were no sta-
tistically significant differences overall in the average
cultivable counts of bacteria (BA and R2A plates) from
all 24 samples compared to the average fungal counts
measured from the same 24 samples (P > 0.05).
Of the total bacterial and fungal isolates that grew,
133 bacterial isolates and 81 fungal isolates were identi-
fied by Sanger sequencing (16S rRNA gene for bacteria;
and ITS region for fungi). The bacterial isolates
belonged to three phyla: Actinobacteria, Firmicutes,
and Proteobacteria. At the genus level, the most
predominant genera were Staphylococcus (26% of total
isolates identified), Pantoea (23%), and Bacillus (11%)
and at the species level, Staphylococcus aureus (10%)
and both Pantoea conspicua (9%) and Pantoea gaviniae
(9%) (Additional file 1: Figure S1A). Although bacterial
counts were similar across all flights (Fig. 2), onlymembers of the family Enterobacteriaceae were cultured
from F3 samples (Additional file 1: Figure S1A). S. aureus
isolates were tested with the Vitek 2 system (BioMerieux,
France) and found to be methicillin-sensitive; however,
these isolates were resistant to penicillin, erythromycin,
gentamycin, and tobramycin [28]. The whole genomes of
20 biosafety level 2 strains, isolated from these samples,
have been sequenced and are publicly available [29].
The fungal population was dominated by Rhodotorula
mucilaginosa belonging to the family Sporidiobolaceae
(41% of the 81 examined fungal isolates) and Penicillium
chrysogenum (15% of 81 fungal isolates) (Additional file 1:
Figure S1B). The whole genome of one Aspergillus
fumigatus strain (isolated from F1, L1 [cupola] sample)
was sequenced, its virulence characterized, and this
information reported elsewhere [30, 31].
qPCR-based microbial population
The 16S rRNA gene and the ITS region were targeted in
PMA-qPCR to measure intact/viable bacterial and fungal
burden, respectively. The changes were not significantly
different (P > 0.05), although the average number of
bacterial 16S rRNA gene copies trended toward increase
from F1 to F3. On the other hand, the ITS region ampli-
cons decreased over time with F3 being statistically
significantly lower than F1 (Fig. 3a). While the average
bacterial (Fig. 3b) and fungal (Fig. 3c) load fluctuated
AB
Fig. 2 Cultivable bacterial and fungal burden from eight locations on the ISS over a 14-month period. a Scatter plot representing the CFU/m2 of
bacteria and fungi at each location across three flight sampling events. Each column represents a Flight and the type of medium the samples were
plated on. Each symbol in that column represents a location sampled during that Flight (N = 8). The colored boxes represent the different types of
plates the samples were cultured on: Reasoner’s 2A (R2A) or blood agar (BA) plates to isolate bacteria and potato dextrose agar (PDA) plates to isolate
fungi. The height of the colored box indicates the average CFU/m2 for samples in that group. F1 = flight 1 sampling session, F2 = flight 2 sampling
session, and F3 = flight 3 sampling session. NB: There was no growth on R2A plates from location 6 sampled during F1 and F2 and from location 3
sampled during F2. b Bar graph representing the CFU/m2 based on location. The number of bacteria isolated on R2A and BA plates were averaged to
obtain a number for “Bacteria.” The bars represent the average CFU/m2 at each location with the capped lines showing the lowest and highest value
in that group (N = 3). The differences in averages observed in (a, b) were not statistically significantly different (Kruskal-Wallis test followed by Dunn’s
post-hoc test P > 0.05). The average number of bacteria and fungi found at each location were similar
Checinska Sielaff et al. Microbiome            (2019) 7:50 Page 5 of 21across locations, there were no statistically significant
differences in microbial load among different locations.
Overall, bacterial loads appeared to be highest at L4
and L5 and lowest at L6, with fungal loads appearing to
be highest at L1, L4, L5, and L7 and lowest at L2. Theaverage number of bacteria present on the ISS during
this study was 3.1 × 109 16S rRNA gene copy number/
m2 and 7.1 × 108 ITS copy number/m2 for fungi. A
comparison between CFU and gene copy number
revealed that on average, 46% of total intact/viable
AB C
Fig. 3 Intact cell membrane/viable bacterial and fungal population aboard the ISS as estimated by PMA-qPCR. a Scatter plot comparing the 16S rRNA
gene (bacteria) and ITS region (fungi) copy numbers of PMA treated samples collected during flights 1, 2, and 3. Each column represents a single flight
and each symbol in a column (labeled with a number) represents one of the eight locations sampled during that flight. The horizontal line in each column
represents the average gene copy number/m2 for each Flight. b Scatter plot comparing 16S rRNA gene and c ITS region (fungi) copy numbers across
locations. Each column “L” followed by a number represents a location and each dot in a column represents the flight it was sampled from. The horizontal
line in each column represents the average copy number/m2 at that location. NB: The 16S rRNA gene copy number was not adjusted to the average
number per bacterial genome. Control samples were measured and found to be at the level of 102 16S rRNA gene copies per μL. Even when the initial
template volume was increased to 10 μL, the expected 20-fold increase in the gene copy numbers was not observed. In panel a, F1-ITS was statistically
significantly higher than F3-ITS (P< 0.05). No statistically significant differences were observed in panel b (P> 0.05). The statistical test was performed with
the Kruskal-Wallis test followed by Dunn’s post-hoc test
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tured, while the remainder were viable but yet to be
cultured (Additional file 1: Figure S1C).
qPCR was also performed on samples that were not
treated with PMA to assess the overall microbial load,
which includes intact/viable cells and compromised/
dead cells. The average 16S rRNA copy number was
7.1 × 109/m2 and the average ITS copy number was5.1 × 108 m2 in these non-PMA-treated samples
(Additional file 1: Figure S1D). When the 16S rRNA
gene copies were summed up for all locations and all
flights, no significant difference was observed with
and without PMA (Additional file 1: Figure S1D).
This calculation may be affected by the artificial
inflation of high copy numbers in samples treated
with and without PMA. For example, the highest
Checinska Sielaff et al. Microbiome            (2019) 7:50 Page 7 of 21copy numbers of a sample with 1010 copies per m2
(for example, Flight 1, Location #2) might mask the
samples with 107 copies per m2 (for example Flight 1,
Location #6). The difference in microbial populations
between PMA and non-PMA-treated samples were
substantial when the data from individual locations
were considered. In general, ~ 0.68% (example: Flight
2; Location #3) to ~ 92.8% (example: Flight 3;
Location #5) of the microbial load was present in the
PMA-treated sample and therefore considered “viable”
(Additional file 1: Figure S1E). Similar reduction in
microbial abundance in PMA-treated samples when
compared to untreated samples was reported in
NASA spacecraft assembly facility (SAF) clean room
floors (4 to 21%; [24]), Lunar Mars Analog Habitat
floors (10 to 40%; [32]), and HEPA filter particulates
of ISS and SAF (1.7 to 66.8%; [2]).
Bacteriome analysis
After processing the raw data from 48 samples (24
PMA samples and 24 non-PMA-treated samples) and
various wipe and reagent controls, amplicon sequence
variants (“ASVs”) (a higher resolution analogue of the
ubiquitous “OTU”) [33] that had a cumulative sum of
more reads in the controls than the cumulative sum of all
the samples, were removed from the dataset. Next, ASVs
that were found to be statistically significantly higher
(ALDEx2 test, P < 0.05) in the control group than in the
sample group were further removed from the dataset.
Additional file 2: Dataset 1A summarizes the ASV read
count in each sample and in each control after the above
quality control measures were implemented. Next, the
program “SourceTracker” was used to predict what percent
of reads in the samples were unique to the samples and
what percent were from “contaminating” ASVs (i.e., those
were represented in a Dirichlet model trained from the
control samples). Additional file 1: Figure S2B summarizes
the results from SourceTracker and shows that contamin-
ation was negligible in 32 out of 48 samples and for the
remaining 16 samples; the contamination was less than 6%
of the total sequences. A canonical correspondence analysis
(CCA) plot verifies that the bacterial communities of the
controls were indeed different than those of the samples
(Fig. 4). The ASV table used for downstream analysis, after
the above quality control measures were implemented and
after verification that the samples represented a unique
microbiome, different than that of the controls, is presented
in Additional file 2: Dataset S1A.
A summary of read counts, number of ASVs, and most
abundant taxa in the samples are presented in
Additional file 3: Table S1. Microbial populations (16S
rRNA gene copies) from eight locations over the span of
14 months were calculated from PMA-treated samples
(viable/intact bacteria) and non-PMA treated samples(dead/compromised bacteria). Figure 5 shows the pro-
portion of different taxa, summarized to the family level,
found in these samples and the variations in their viable
populations. In both the PMA- and non-PMA-treated
groups, Enterobacteriaceae dominated and made up a
little over 50% of the sequences detected in all 24 sam-
ples combined, followed by Methylobacteriaceae (~ 13%)
and Staphylococcaceae (~ 10%).
Of interest was whether the ISS environmental micro-
biome, and especially the most abundant taxa, changed
over time and across locations. The taxa present in the
non-PMA-treated (Fig. 6a) and PMA-treated (Fig. 6b)
groups showed the same temporal progression: The rela-
tive abundances of Enterobacteriaceae was highest during
F3 and lowest during F2, whereas Methylobacteriaceae
was the lowest during F3 and highest during F1. Paeniba-
cillaceae and members of the class Bacilli and order Bacil-
lales had high relative abundances during F2, and almost
negligible amounts during F1 and F3. Interestingly, F1 and
F2 had higher relative abundances of sequences that could
not be identified, compared to F3. Statistical analysis using
ALDEx2 confirmed that the relative abundances over the
three flight sessions were different for all taxa shown,
expect for Paenibacillaceae in the non-PMA group
(Fig. 6a) and Paenibacillacae, Staphylococcaceae, and
Sphingomondales in the PMA-treated group (Fig. 6b).
Unlike the differences observed over time, no statistically
significant differences in relative abundances were observed
between the eight locations (Fig. 6c, d); however, some
interesting trends are worth noting: Enterobacteriaceae was
well represented at each location, with the highest relative
abundance observed at L1, L5, and L6.Methylobacteriaceae
was also highly represented across locations except for L2,
L5, and L6.
The barplot in (Additional file 1: Figure S3) provides a
more detailed representation of the relative abundances
of family level taxa in each sample. Upon visual inspec-
tion, it appears that bacterial diversity within a sample
was the lowest during Flight 3, which consisted predom-
inately of Enterobacteriaceae, and was the highest during
F2. This observation was statistically confirmed (P <
0.05) by calculating (i) Shannon’s diversity index, which
measures both taxa presence and relative abundance and
(ii) taxon richness, which reports the number of unique
taxa in a sample (Additional file 1: Figure S4A and B).
Noteworthy, both alpha diversity (measured with Shan-
non’s diversity index and taxa richness) and beta diversity
(measured with ALDEx2) showed no differences between
PMA and non-PMA treated samples across all three
flights, suggesting that the DNA recovered from the ISS
were from intact/viable organisms.
When the ASVs were summarized to the genus level,
121 taxa were detected, 77 of which could be assigned
to known genera (Additional file 1: Figure S5). Of those
Fig. 4 Assessment of bacterial contamination in the ISS environmental samples. Canonical correspondence analysis (CCA) highlighting the differences
among species constituents found in samples, treated or untreated with PMA, that were collected from the International Space Station (Flights 1–3)
and controls. “DNACTL” represents the DNA extraction control (molecular grade water extracted instead of a sample) and “CTL” represents cloth wipes
that were exposed to the environment but not used to sample a surface. F1, F2, F3 denotes the flight
Checinska Sielaff et al. Microbiome            (2019) 7:50 Page 8 of 2177 genera, 68% of them are known constituents of the
human microbiome and the remaining 32% are found in
environments such as soil and water.Mycobiome analysis
Amplicon sequencing of the fungal ITS region was per-
formed on samples collected during F1 and F2. Since
F3 exhibited low abundance of cultivable fungal counts,
it was not possible to generate amplicons for further se-
quencing. Similar to what was done with bacterial se-
quences, OTU counts that were higher across controls
compared to samples were removed from the dataset.
For one OTU, even though the cumulative read count
of the controls was 33 times lower than the samples,
since the count was 300,000, it was removed from the
dataset. Additional file 2: Dataset S1B shows the fungal
OTU table that was used for analyses after OTUs asso-
ciated with controls were removed. The SourceTracker
results for the mycobiome are shown in Additional
file 1: Figure S6A and the total OTU read count for the
sample and control wipes is presented in Additional
file 1: Figure S6B.
The fungal population consisted of four genera plus
members belonging to one phylum, two classes, and four
families, in addition to sequences that could not be
classified (Additional file 1: Figure S7). The temporal
and spatial distribution of the five most relatively abun-
dant taxa are shown in Additional file 1: Figure S8. With
the exception of Sporidiobolaceae which was higher inF2 compared to F1, there were no other statistically
significant differences in fungal taxa between flights.
Unlike bacteria, fungal diversity within samples (i.e.,
alpha diversity) did not change between Flight 1 and 2
(Additional file 1: Figure S4C and D). Similar to what
was observed with bacteria, alpha and beta diversity
were similar between the PMA- and non-PMA treated
samples across these two flights.
Comparison of ISS environmental microbiome
with Earth microbiome
Publicly available sequences of PMA-treated samples
collected from two JPL clean rooms, ISS dust, ISS HEPA
filters, and surface samples from an inflated Lunar Mars
analogue habitat (ILMAH) were compared. As is clear
from the PCoA plot shown in Additional file 1: Figure
S9, the ISS surface microbiome is a unique microbiome,
differing from the ISS-dust, ISS-HEPA, JPL clean rooms,
and Lunar/Mars-like human-occupied habitats. In
addition, PMA-untreated microbial diversity associated
with ISS environments was compared to results obtained
from the Earth Microbiome Project, hospital environ-
ment, and office spaces. The ISS samples grouped with
the built environment data, as shown in Fig. 7. This rela-
tionship also suggests that, as expected, the environmen-
tal locations sampled on the ISS harbored microbes
more similar to those on animal surfaces (e.g., skin) than
to environmental soil samples. Similar pattern was seen
with built environmental samples from Earth. Thus, the
ISS samples resembled other Earth built environment
Fig. 5 Pie chart showing the relative abundances of taxa identified on the ISS. 16S rRNA gene sequencing was performed on 24 wipes, taken from 8
locations throughout the ISS (see Fig. 1) during 3 flight sampling sessions, spanning 14months. For each sample, half was treated with PMA (N= 24) to
detect intact/viable bacteria, while the remaining half was left untreated (N= 24) to determine the total bacterial community (both dead cells/cells with
a compromised cell membrane and intact/viable). The sequences obtained from both the untreated and PMA-treated samples were summarized to the
family level and the relative abundances depicted in this pie chart. In total, 68 different family level taxa were detected but only the most relatively
abundant taxa are listed in the legend. A full list of organisms detected can be found in Dataset S1. Those sequences that could not be resolved to the
family level are prefixed with either “o” for Order or “c” for Class
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differences in DNA extraction and PCR amplification)
were relatively small compared to the differences among
different sample types.
Using the unrarefied data, the unique sub-operational
taxonomic units (sOTUs) present in the ISS data were
also compared with other built environment datasets
collected on various locations of Earth to determine
whether any sOTUs appear to be unique to the ISS. For
this analysis, only Flight 3 data were included since all
the other built environment datasets used the same pri-
mer set. The sOTUs observed in the ISS controls were
removed. There were four sOTUs that appear to be
unique relative to all the built environment datasetsanalyzed (see Additional file 4: Table S4), although they
accounted for a very small total amount of the sequence
mass (~ 0.0005% of the reads). These unique sOTUs
exhibited high identity to Bacteroides sp., Gottschalkia
acidurici, Paenibacillus thailandensis, and Thermus
thermophilus based on BLAST to nr/nt [34]. One single
sOTU belonging to T. thermophilus was unique in Flight
3 samples and was not observed in the Earth Microbiome
Project, nor in other built environment datasets on Earth.
Discussion
The ISS environmental microbiome was characterized
from eight locations throughout the ISS during three
flight sampling events over a period of 14 months.
A B
C D
Fig. 6 Temporal and spatial distribution of the ISS microbiome over 14 months and across eight locations. Boxplots show the temporal (a, b) and spatial
(c, d) distribution of the most relatively abundant family level taxa (as presented in Fig. 4). The box in each graph signifies the 75% (upper) and 25% (lower)
quartiles and thus shows the percent abundances for 50% of the samples (N= 8). The black line inside the box represents the median. The bottom
whisker represents the lowest datum still within the 1.5 interquartile range (IQR) of the lower quartile, with the top whisker representing the highest datum
still within the 1.5 IQR of the upper quartile. Open circles are outliers. “o” and “c” represent sequences that could not be taxonomically assigned past the
order or class level respectively. “F” indicates Flight and “L” indicates Location. a Temporal distribution over time in untreated samples. All taxa showed
statistically significant changes over time except Paenibacillaceae (denoted by *). b Temporal distribution in PMA-treated samples. Taxa showed statistically
significant changes over time except Paenibacillacae, Staphylococcaceae, and o_Sphingomondales (denoted by *). Spatial distribution in untreated samples
(c) and in PMA treated samples (d). There were no statistically significant differences in these taxa across the eight locations. Significance was measured
using ALDEx2 and based on the Benjamini-Hochberg corrected P value of the Kruskal-Wallis test (significance threshold, P< 0.05). Those sequences that
could not be resolved to the family level are prefixed with either “o” for Order or “c” for Class
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Fig. 7 Comparison of ISS environmental microbiome with microbiomes of Earth. Principal coordinates analysis of unweighted UniFrac distances from the
Earth Microbiome Project [96], the Hospital Microbiome Project ([5], Qiita study 10,172), and the Office Succession Study [105] depicting a PC1 vs. PC2 and
b PC1 vs. PC3. The Hospital Microbiome Project and Office Succession Study are composed predominantly built environment samples (e.g., walls, floors,
etc.). All three ISS flight sample sets group with the built environment samples. The primary separation along PC1 is environmental or plant associated
samples vs. animal surface, secretion, or built environment. The primary separation along PC3 is whether a sample is associated with the animal gut
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distribution of microbial populations on the ISS. This
is the first study to utilize culture, qPCR, and ampli-
con sequencing to study the surfaces of the US
segment and revealed a diverse intact/viable popula-
tion of bacteria and fungi that changed over time but
were similar across locations.
Several studies have been carried out to measure
microbiological cleanliness of the ISS environment using
cultivation-based approaches since the inception of this
closed system [35]. Recently, several ISS surfaces in the
US nodes [36] and Japanese Kibo module [37] were
swabbed and targeted amplicon sequencing carried out.
However, these studies did not measure the intact/viable
microbiome which therefore could not be compared to
culture counts nor provide an assessment for crew risk.
Previous reports on the ISS intact/viable microbiomes
on the ISS were only examined from air filters and deb-
ris collected via vacuum cleaner bag [2]. The ISS is a
unique environment and one question that is of interest
to many is how this intact/viable microbiome compares
to other closed, regulated environments (Additional
file 1: Figure S9 and Fig. 7). The ISS environmental
microbiome resembles that of animal skin surfaces
rather more than the soil microbiome. This might be
due to the fact that cargo sent to the space station was
cleaned thoroughly, and hence soil-associated microor-
ganisms were not present.
The predominant organisms on ISS surfaces con-
sisted of those that are associated with humans, with
some considered opportunistic pathogens on Earth.
As to whether they could cause disease in astronauts
on the ISS is unknown, as it would depend on thehealth status of each individual and how these organ-
isms function while in the space environment.
Regardless, the detection of possible disease-causing
organisms highlights the importance of further gen-
omic and transcriptomic studies to examine how
these ISS microbes function in space and how they
may impact astronauts’ health. Correlating viable but
opportunistic pathogens with crew member health is likely
to raise too many questions about access to the crew
microbiome data which is not yet publicly available, and
about statistical power: because the ISS has few occupants
and high turnover, identifying statistically relevant trends in
crew member health that correlate with environmental
microbiomes is not possible. From the time the ISS was
built in 1998, as of Aug 3, 2017, 222 astronauts visited the
ISS, and microbial signatures left behind by previous astro-
nauts might interfere with the predictions. Consequently,
the present ISS environmental microbial metrics could not
be linked to any particular crew member. Since there were
no differences in community composition and richness be-
tween PMA- and non-PMA treated samples, it suggests
that the DNA analyzed from these possible opportunistic
pathogens residing on the ISS environmental surfaces are
indeed intact/viable and not dead organisms.
Noteworthy, approximately 46% of intact/viable bac-
teria and 40% of intact/viable fungi could be cultured
with the culture media used during this study. This
percentage is high when compared to spacecraft assem-
bly cleanrooms on Earth where only 1 to 10% of intact/
viable microorganisms can be cultured [38]. The possible
explanation is that the ISS is not deprived of nutrients
like spacecraft assembly cleanrooms, and while this is a
hermetically sealed environment, it is exposed to
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given time) and cargo (delivered ~ 4–6 times per year).
Furthermore, no relationship was found between micro-
bial load and sample processing time (F1: 7 days, F2:
9 days, and F3: 6 days).
Many of the organisms detected on the ISS are known to
form biofilms that belong to both bacterial (Acinetobacter,
Sphingomonas, Bacillus, Burkholderia, Corynebacterium,
and Klebsiella) [39] and fungal (Penicillium, Aspergillus,
Cryptococcus, and Rhodotorula) [40] genera. This could
pose problems for astronauts if they do become infected as
biofilms are known to promote resistance to antibiotics
[41]. Also, biofilm formation on the ISS could decrease
infrastructure stability by causing mechanical blockages,
reducing heat transfer efficiency, and inducing microbial
influenced corrosion [42]. Some of the microorganisms
that were identified on the ISS that have been impli-
cated in microbial-induced corrosion on Earth are
Methylobacterium, Sphingomonas, Bacillus, Penicillium,
and Aspergillus [43–46]; however, the role they play in
corrosion aboard the ISS remains to be determined.
Elucidating the potential ability to form biofilms and the
magnitude of actual biofilm formation on ISS surfaces is
important during long-term space missions to maintain
structural stability of the crew vehicle when routine in-
door maintenance cannot be as easily performed.
As expected, culture-based analysis did not detect
as many genera as that with amplicon sequencing;
however, its importance should not be overlooked as
species level identity of ISS microbial constituents
could be obtained when isolates were available. Fur-
thermore, isolating organisms allowed us to conduct a
separate study to examine the influence of micrograv-
ity and radiation on antibiotic resistance and viru-
lence [47] and to obtain whole genome sequences of
organisms that grow in space, for future comparative
genomics [29]. Similar to a previous study on ISS
HEPA filters, where the novel organism, Solibacllus
kalamii [48]was able to be identified only through
culture analysis, this study has also allowed us to
detect a recently identified novel species Enterobacter
bugandensis that was associated with human disease
on Earth [49, 50]. A high percentage of the cultivable
population represented opportunistic pathogens such
as S. aureus, Staphylococcus hominis, Staphylococcus
haemolyticus, P. conspicua, Acinetobacter pittii,
Klebsiella quasipneumoniae, and A. fumigatus. This
could have potential health impacts on astronauts, as
bacteria and fungi have been shown to be transferred
between surfaces and humans upon contact [51]. The
scope of the present study was not to determine
whether these microorganisms were more virulent or
resistant to antibiotics than on Earth but the whole
genome sequences have been published for theisolated biosafety level 2 microorganisms [29] and
comparative genomics of these ISS isolates with Earth
strains is now possible for further investigation.
Members of the family Staphylococcaceae and
Enterobacteriaceae were the most predominant organ-
isms on ISS surfaces of the US module, similar to what
has been published for the Japanese module of the ISS
[52], and were detected in almost every sample by both
culture and amplicon sequencing (Additional file 1: Fig-
ure S10). Both are human-associated organisms, with
Staphylococcaceae commonly found on the skin and in
the nasal passage, and Enterobacteriaceae commonly
associated with the gastrointestinal tract. These two
taxa are also abundant in fitness centers [53], office
buildings [54], and hospitals [5], suggesting that the ISS
is similar to other built environments on Earth, in that
its microbiome is shaped by human occupation [32].
On Earth, it has been observed that incoming intensive
care unit (ICU) patients have a significantly higher risk
of acquiring infections if the previous occupant was a
carrier, despite terminal cleaning of the bed and the
room [55–57]. Thus, habitation of the same area, re-
gardless of whether individuals interact or not, may
contribute to disease spread. Further studies assessing
how long organisms survive on ISS surfaces and how
readily they can be passed on from one individual to
another in space can lead to the development of coun-
termeasures to minimize the spread of infections from
one astronaut to another during simultaneous or even
separate flight missions.
Methylobacteriaceae/Methylobacterium was also dom-
inant across the ISS and could be cultured from several
samples. This is a hardy organism that can withstand
harsh conditions, such as ionizing radiation and
strong cleaning detergents and has previously been
found in NASA spacecraft assembly clean rooms [58],
hospital ICUs [59], and the MARS500 habitat [60].
Moraxallaceae, another abundant organism on the
ISS, also thrives in harsh conditions, being present in
higher relative abundances in spacecraft assembly
cleanrooms [61], areas of the home that utilize a lot
of chemicals (i.e., washing machine) [62], and deep
sea sediment of inactive hydrothermal vents [63].
R. mucilaginosa was the predominant fungal isolate from
the culture analysis, and belongs to the Sporidiobolaceae
family which was found in high relative abundances across
the ISS with amplicon sequencing. This organism can sur-
vive inside dishwashers despite high temperatures and
chemical exposure [64].
Numerous studies conducted on Earth have shown
that the type and amount of human activity in a particu-
lar location impacts that indoor microbiome [65–67]
and while there were no differences in the average mi-
crobial load (by culture and qPCR) nor community
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were variations between sampling points across different
locations. Among the eight locations sampled (Table 1),
location #6 (permanent multipurpose module [PMM]
port 1) exhibited low concentrations of cultivable (Fig. 2),
viable (Fig. 3a), and total (data not shown) microbial
burden. The PMM is a specific location within the Node
1 Nadir module of ISS (Fig. 1) to store bags intact as
opposed to open and place them into racks. Minimum
crew activities are expected in PMM location #6 and
hence microbial abundance might be minimal compared
to other locations that are heavily occupied by astro-
nauts in a day to day activities such as observing window
cupola (location #1), toilet (location #2), ARED exercise
platform (location #3), dining table (location #4)
performing several experiments, or sleeping quarters (lo-
cation #8). In a study performed by Mayer et al. [32] in
an inflated lunar/Mars analog habitat, the cultivable bac-
terial load was in the range of 103–105 per m2 after the
student crew inhabited the analog station. There were
no significant changes in microbial load between the
more active areas like the laboratory and other locations,
while bedroom cultivable bacterial load increased toward
the end of 30-day occupation. The fungal cultivable
population was lower than bacterial, but it was in the
range from 102 to 104 per m2 [68]. In contrast, the ISS
results showed that cultivable microbial load were not
uniform between locations and warrant more study.
In general, temporal differences were observed within
the bacterial population: F2 samples had higher microbial
diversity (alpha diversity) than F1 and F3 samples; only
Enterobacteriaceae were cultured from F3 samples and
nine out of the ten most relatively abundant family level
taxa differed over the three flights. These temporal differ-
ences may be due to the different occupants onboard the
ISS during each of the flight sampling session. Earth in-
door microbiome studies have shown that humans shed
microbes to indoor surfaces upon contact, playing a
pivotal role in shaping the indoor microbiome [17]. Simi-
larly, a study of the inflatable Lunar/Mars analog con-
ducted here on Earth showed differences in bacterial
communities between day 0 (before human occupation)
and after 30 days of habitation [32] showing the effects of
human occupation on indoor microbial communities in a
space-like environment. Of the nine astronauts that were
present aboard the ISS from F1 to F2 (2 months apart),
only three were present during both flights and none of
the astronauts present during F1 or F2 were on the ISS
during F3 sampling. Further studies that collect microbial
information from astronauts in parallel with air and
surface samples would help elucidate how much of an im-
pact astronaut have toward the ISS microbiome. Unlike
bacteria, fungal communities were stable over time with
no temporal differences, and this could be due to the factthat fungal and bacterial communities follow different
environmental determinants [69].
It should be noted that F3 samples were sequenced separ-
ately from the F1/F2 samples and used different but similar
V4 primers (see “Materials and methods” section for more
details). Due to the SpaceX-7 launch failure and the uncer-
tainty of when F3 sampling kits would be flown to the ISS
for sampling, it was not possible to sequence F3 with F1/
F2. However, the samples were collected in the same man-
ner, processed identically, and the same protocol used for
DNA extraction. We do not believe that the choice of
primers, nor the separate sequencing runs, have influenced
the differences in temporal distribution presented in this
manuscript for the following reasons: (i) Additional file 5:
Table S2 shows the organisms that were statistically signifi-
cantly different over time and shows the efficiency of each
primer pair in detecting these organisms, which are almost
identical. (ii) A metagenomics analysis was performed using
the same DNA samples as for amplicon sequencing and all
three flights were sequenced simultaneously and without
multiple displacement amplification prior to sequencing.
The family level barplot for this metagenomics data in Add-
itional file 1: Figure S11 shows the same pattern distribu-
tion of taxa, as presented in Additional file 1: Figure S3 for
the amplicon sequencing. (iii) Lastly, all statistical analyses
were performed with ALDEx2 which estimates per-feature
technical variation within each sample using Monte-Carlo
instances drawn from Dirichlet distributions. ALDEx2 uses
the centered log-ratio transformation that ensures that data
are scale invariant and sub-compositionally coherent mean-
ing that all samples are numerical consistent with each
other, regardless of the total sequencing read capacity at the
time of sequencing [70, 71]. This ensures that the statistical
results are robust and are not influenced solely by the dif-
ferential detection of ASVs that can occur during different
sequencing runs.
Many 16S rRNA and ITS sequences could not be identi-
fied via amplicon-targeted analyses, but a metagenomics
approach recently conducted identified 318 bacterial and
fungal species in these samples [72]. In addition, shotgun
metagenome analysis carried out by Singh et al. [72] from
the same samples revealed that reads associated with
carbohydrate metabolism, amino acid derivatives and
cofactors, vitamins, etc. were the highest among all three
flights. Similarly, computational analyses showed that the
Legionella resistome, cobalt-zinc-cadmium resistance, and
multi-drug resistant resistance efflux pump were high on
all flights and all locations. The shot-gun reads associ-
ated with antimicrobial resistant genes in Flight 3 in-
creased by twofold when compared with Flights 1 and
2 which also predicted the persistence of opportunis-
tic pathogens in Flight 3 samples [72]. Collective
beta-Lactam resistance derived from the metagenome
sequence analysis shows that physical (OmpF, OmpC),
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degradational (AmpC), and MDR efflux pump (OMP,
RND, MPF) mechanisms were allocated by the micro-
organisms on the ISS [72].
Exploring the spatial and temporal distribution of in-
tact/viable microbial populations of closed systems such
as the ISS will facilitate planning of future human habita-
tion of Moon, Mars, and beyond. Accumulation of intact/
viable microbial cells in a confined environment poses a
health risk to all inhabitants. This study on bacterial and
fungal load and diversity across the ISS provides a com-
prehensive catalog of what can be found in closed space
systems and can be used to develop safety measures for
NASA to meet the requirements for long-term space
travel or living in space. The implications of this study are
not only limited to space biology but can have significant
impact on cleanrooms here on Earth such as those in the
pharmaceutical and medical industries.
Materials and methods
Sample kit preparation and sample collection
Sampling wipes were prepared at the Jet Propulsion La-
boratory (JPL; Pasadena, CA). Briefly, each polyester wipe
(9″ × 9″; ITW Texwipe, Mahwah, NJ) was folded two
times and soaked in 15 mL of sterile molecular grade water
(Sigma-Aldrich, St. Louis, MO) for 30 min followed by the
transfer to a sterile zip lock bag [73]. The sampling kit was
assembled at NASA Ames Research Center (ARC, Moffett
Field, CA). The implementation team at NASA ARC deliv-
ered the kit to the Cargo Mission Contract at Johnson
Space Center (Texas) which was then transferred to Ken-
nedy Space Center (Florida) in order to be loaded into the
Space Exploration Technologies (SpaceX) Dragon space-
craft prior to launch. Each sampling kit was sent to the ISS
onboard the SpaceX-5, -6, -8, rockets and returned to the
Earth onboard the Russian vehicle (Soyuz TM-14) and
Dragon capsule (SpX-6 or -8). Eight different locations were
sampled on the ISS using the polyester wipes described
above (see Fig. 1 for a summary of the sampling locations).
The metadata associated with the samples and collections
is summarized in Additional file 6: Table S3.
The study requirements stated that there should be no
cleaning at least 4 days prior to sampling. When the clean-
ing occurred during the weekends, it was done at the crew’s
discretion without suggestions about the specific locations,
therefore following the typical routine of activities on the
ISS. The disinfectant wipes that are used in the ISS contain
octyl decyl dimethyl ammonium chloride (0.0399%), dioctyl
dimethyl ammonium chloride (0.01995%), didecyl dimethyl
ammonium chloride (0.01995%), alkyl (50% C14, 40% C12,
10% C16) dimethylbenzylammonium chloride, and
dimethylbenzylammonium chloride (0.0532%). During
each flight, one astronaut performed all the sampling
and used the wipes to sample one square meter. Anew pair of individually packed sterile gloves (KIM-
TEC Pure G3 White; Nitrile Clean-room Certified;
Cat. HC61190) were used before sampling the next
location. The crew was instructed to collect samples
from the same surfaces during all three sampling ses-
sions. A control wipe (environmental control) was taken
out from the Zip lock bag, unfolded, waved for 30 s, and
packed back inside a new sterile zip lock. One control wipe
was included for each flight session. Similarly, an unused
wipe that was flown to the ISS and brought back to Earth
along with the samples served as a negative control for ster-
ility testing. If field controls (wipes that were exposed to the
ISS environment but not used in active sampling) showed
any signs of microbial growth, then negative controls would
be assayed for cultivable counts to check sterility of the
wipes used for sampling. However, none of the field controls
showed any CFUs for all three flights. The samples were
stored at room temperature in orbit. After sample collection,
samples were returned to Earth after 7 days for Flight 1,
9 days for Flight 2, and 6 days for Flight 3. The kits were de-
livered to JPL immediately after arrival to Earth at 4 °C with
processing at JPL commencing within 2 h of receipt.
Sample processing
Sample processing took place in a ISO 7 (10K class) clean-
room at JPL. In a certified biosafety cabinet, each wipe was
aseptically removed from the zip lock bag and transferred
to a 500 mL bottle containing 200 mL of sterile
phosphate-buffered saline (PBS; pH 7.4). The bottle with
the wipe was shaken for 2 min followed by concentration
with a Concentrating Pipette (Innova Prep, Drexel, MO)
using a 0.22 μm Hollow Fiber Polysulfone tips (Cat #:
CC08022). Each sample was concentrated to 4 mL with
PBS elution fluid (Cat #). Then, 3 mL of this concentrated
sample was split into two 1.5 mL aliquots. One aliquot was
treated with PMA (18.25 μL of 2 mM PMA, resulting in a
final concentration of 25 μM) to assess cells that were vi-
able or had an intact cell membrane [24], while the second
aliquot was handled in a similar manner but without the
addition of PMA. The PMA and non-PMA-treated aliquots
were incubated in the dark at RT for 5 min, followed by
15 min of photoactivation using the PMA-Lite™ LED
Photolysis Device, specifically designed for photoactivation
of PMA (Biotium, Hayward, CA). The PMA- and
non-PMA -treated aliquots were then split into two
0.75 mL aliquots. One aliquot was transferred to bead
beating tubes containing Lysing Matrix E (MP Biomedi-
cals, Santa Ana, CA), followed by bead beating for 60 s
using the vortex sample holder (MO Bio, Carlsbad, CA).
The bead-beaten aliquot and the aliquot without bead
beating were combined for their corresponding
PMA-treated and non-treated samples. DNA extraction
was performed with the Maxwell 16 automated system
(Promega, Madison, WI), in accordance with manufacture
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purification kit. A Maxwell control (MC) without any
sample added in its cartridge was run concurrently with
each flight sample. The extracted DNA was eluted in
50 μL of water and stored at − 20 °C until further analysis.
Estimation and identification of cultivable microbial
population
The concentrated samples were diluted in PBS (up to 10−6
of each original sample) and 100 μL of each dilution was
plated (in duplicate) on Reasoner’s 2A agar (R2A for envir-
onmental bacteria), Potato Dextrose Agar with chloram-
phenicol (100 μg/mL; PDA for fungi), and blood agar (BA
for human commensals; Hardy Diagnostics, Santa Maria,
CA). R2A and PDA plates were incubated at 25 °C for
7 days and BA plates at 35 °C for 2 days at which time col-
ony forming units (CFU) were calculated. Whenever pos-
sible, a minimum of five isolates of distinct morphologies
were picked from each plate, from each ISS sampling loca-
tion. The isolates were then archived in semisolid R2A or
PDA slants (agar media diluted 1:10) and stored at room
temperature. Once a culture was confirmed to be pure,
two cryobead stocks (Copan Diagnostics, Murrieta, CA)
were prepared for each isolate and stored at − 80 °C. A
loopful of purified microbial culture was directly subjected
to PCR and the targeted fragment was amplified (colony
PCR), or DNA was extracted with the UltraClean DNA
kit (MO Bio, Carlsbad, CA) or Maxwell Automated
System (Promega, Madison, WI). The extracted DNA was
used for PCR to amplify the 1.5 kb 16S rRNA gene in
order to identify bacterial strains. The following primers
were used for the 16S rRNA gene amplification: the for-
ward primer, 27F (5′-AGA GTT TGA TCC TGG CTC
AG-3′) and the reverse primer, 1492R (5′-GGT TAC
CTT GTT ACG ACT T-3′) [74, 75]. The PCR conditions
were as follows: denaturation at 95 °C for 5 min, followed
by 35 cycles consisting of denaturation at 95 °C for 50 s,
annealing at 55 °C for 50 s, and extension at 72 °C for
1 min 30 s and finalized by extension at 72 °C for 10 min.
The ITS region was amplified using the forward primer
ITS1F (5′-TTG GTC ATT TAG AGG AAG TAA-3′) [76]
and reverse primer Tw13 (5′-GGT CCG TGT TTC AAG
ACG-3′) [77] to obtain a ~ 1.2 kb product. The PCR con-
ditions were as follows: initial denaturation at 95 °C for
3 min followed by 25 cycles of 95 °C for 50 s, annealing at
58 °C for 30 s, and extension at 72 °C for 2 min, followed
by a final extension at 72 °C for 10 min. The amplicons
were inspected on a 1% agarose gel. When bands for
products were visible, amplification products were treated
with Antarctic phosphatase and exonuclease (New Eng-
land Biolabs, Ipswich, MA) to remove 5′- and 3′-phos-
phates from unused dNTPs before sequencing. The
sequencing was performed by Macrogen (Rockville, MD)
using 27F and 1492R primers for Bacteria, and ITS1F andTw13 primers for Fungi. The sequences were assembled
using SeqMan Pro from DNAStar Lasergene Package
(DNASTAR Inc., Madison, WI). The bacterial sequences
were searched against EzTaxon-e database [78] and the
fungal sequences against the UNITE database [79]. The
identification was based on the closest percentage similar-
ity (> 97%) to previously identified microbial type strains.qPCR assay
Following DNA extraction with the Maxwell Automated
system, quantitative polymerase chain reaction (qPCR),
targeting the partial 16S rRNA gene (bacteria) or partial
ITS region (fungi), was performed with SmartCycler
(Cepheid, Sunnyvale, CA) to quantify the microbial
abundance. Primers targeting the partial 16S rRNA gene
were 1369F (5′-CGG TGA ATA CGT TCY CGG-3′)
and modified 1492R (5′-GGW TAC CTT GTT ACG
ACT T-3′) [80]. Primers targeting the ITS region were
NS91 (5′-GTC CCT GCC CTT TGT ACA CAC-3′) and
ITS51 (5′-ACC TTG TTA CGA CTT TTA CTT CCT
C-3′) [81]. Each 25-μL reaction consisted of 12.5 μL of
2X iQ SYBR Green Supermix (BioRad, Hercules, CA),
1 μL each of forward and reverse oligonucleotide
primers (10 μM each), and 1 μL of template DNA (PMA
treated and non-treated samples). Each sample was run
in triplicate; the average and standard deviation were
calculated based on these results. Purified DNA from a
model microbial community [82] served as the positive
control and DNase/RNase free molecular-grade distilled
water (Promega, Madison, WI) was used as the negative
control in each run. The reaction conditions were as fol-
lows: a 3-min denaturation at 95 °C, followed by 40 cycles
of denaturation at 95 °C for 15 s, and a combined anneal-
ing and extension at 55 °C for 35 s. The number of gene
copies in the samples were determined by running a
standard curve, which was generated using serial dilutions
(108–102) of Bacillus pumilus SAFR-032 16S rRNA gene
as described previously [2]. The qPCR efficiency was ~
98% for each run. The negative control values were not
deducted since the values were at ~ 100 copies per 1 or
10 μL and not scalable (yielded the same results despite
using 1 μL and 10 μL of DNA templates was used).Illumina sequencing - Bacteria
Flight sampling 1 and 2
Bacterial diversity was assessed by analyzing the V4
hypervariable region of the 16S rRNA gene coding se-
quence. Amplification was performed with the following
primer pair: forward primer, A519F (new nomenclature:
S-D-Arch-0519-a-S-15), 5′-CAG CMG CCG CGG
TAA-3′, and the reverse primer 802R (new nomencla-
ture: S-D-Bact-0785-b-A-18,) 5′-TAC NVG GGT ATC
TAA TCC-3′ [83]. Expected amplicon size is 283 for
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deposited in the Silva SEED Reference Database [84].
Fungal diversity was assessed by analyzing the ITS1
region between 18S and 5.8S rRNA coding sequences.
Amplification primers were ITS1-F_KYO2 (5′-TAG
AGG AAG TAA AAG TCG TAA-3′) and ITS2_KYO2
(5′-TTY RCT RCG TTC TTC ATC-3′) [85].
Expected amplicon length distribution is 271 ± 90 bp
for Ascomycota, 284 ± 42 bp for Basidiomycota, and
216 ± 94 bp for non-Dikarya species [86].
PCR synthesis of SSU-V4 and ITS1 amplicons was per-
formed using Q5 High-Fidelity PCR Kit (New England
Biolabs, Ipswich, MA) according to the manufacturer’s in-
structions. The 40-μL reaction mixtures were incubated
under the following conditions: initial denaturation at 94 °
C for 3 min followed by 35 cycles of 94 °C for 30 s, 47 °C
for 30 s, and 72 °C for 90 s, with a final extension at 72 °C
for 5 min. Afterwards, each reaction mixture was fraction-
ated by electrophoresis on 2% agarose gel, recovering all
PCR products in the size range of 200 to 400 bp. The
amplicons were isolated from gel slices using silica
spin-columns [87], and eluted with nano-pure water. The
purified amplicons were tagged with barcoded Illumina
adapters using TruSeq DNA PCR-Free Library Prep Kit
LT (Illumina, San Diego, CA) according to the manufac-
turer’s instructions. The libraries were quantified on a
TBS-380 Fluorimeter (Turner BioSystems, Sunnyvale,
CA) using PicoGreen dye (Invitrogen, Carlsbad, CA) as a
dsDNA-binding fluorogenic reagent. The dsDNA length
distribution in individual library preps was assessed by
analysis on a 2100 Bioanalyzer with High Sensitivity DNA
chip (Agilent Technologies, Santa Clara, CA). The librar-
ies were pooled to be present at equimolar concentrations
in each mixed sample with total concentration of 10 nM.
The first mixed sample contained 20 16S rRNA-V4 librar-
ies and 17 ITS1 libraries representing the first ISS sam-
pling session together with corresponding controls. The
second mixed sample contained 21 16S rRNA-V4 libraries
and 20 ITS1 libraries representing the second ISS
sampling session and corresponding controls. The two
sample sets were sequenced on a NextSeq 500 Sequencing
System (Illumina, San Diego, CA) with NextSeq 500/550
Mid-Output v2 Kit for 300 main and 6 index cycles.
Flight sampling 3
DNA from these samples was amplified using 1 μL of
gDNA in triplicate 25 μL reactions using Platinum Hot
Start PCR master mix (Thermo Fisher cat# 13000012)
and custom golay barcoded primers of the 16S V4 re-
gion, 515fB (5′-GTG YCA GCM GCC GCG GTA A-3′)
and 806rB (5′-GGA CTA CNV GGG TWT CTA
AT-3′), (expected amplicon size ~ 291 bp) as described
in the http://www.earthmicrobiome.org for 94 °C 3 min
and 35 cycles at 94 °C 45 s, 50 °C 60 s, 72 °C 90 sfollowed by 72 °C 10 min and held at 4 °C. Triplicate re-
actions were then pooled into a single tube and quality
assessed. The amplicons were run on a 2% agarose gel
and quantified using PicoGreen to access quality and
relative quantity. All samples were pooled in equal vol-
ume into a single tube and then processed through the
MoBio PCR cleanup kit to remove adaptors and primers.
Final cleaned pools were then sequenced on a HiSeq
2500 2 × 150 bp Rapid Run.
Illumina sequence processing—Bacteria (flight 1, 2, and 3)
For F1 and F2 samples, the forward reads were
de-multiplexed by using fastq-multx v. 1.02.772, a
tool from ea-utils software package [88], with the
forward amplification primers for prokaryotes as
search targets. The reads were further processed to
remove all remaining sequences of the amplification
primers and the Illumina TruSeq adapters from their
3′-ends using consecutively fastq-mcf v. 1.04.807
program [88] for exact sequence search, and agrep
(http://www.tgries.de/agrep/) and treagrep (0.8.0:
https://github.com/laurikari/tre/) programs for search
allowing up to three mismatches between the
primers/adapters and the reads to accommodate for
sequencing errors. The F3 reads were demultiplexed
and adaptors removed using Qiita (http://qiita.ucsd.edu)
using the parameters max_barcode_errors: 1.5; barcode_-
type: golay_12; and phred_quality_threshold: 3.
The demultiplexed reads for F1, F2, and F3 were then
processed using the DADA2 pipeline, trimming the 3′
end of the forward reads to a length of 130 bp, and set-
ting the filter parameters to maxN = 0, maxEE = 2,
trunQ = 2, and rm.phix = True. The DADA2 pipeline
(https://benjjneb.github.io/dada2/index.html) was
followed to obtain an amplicon sequence variant table
(“ASV” table), a “higher resolution analogue of the ubi-
quitous OTU table”. Taxonomy was assigned used the
SILVA reference database.
Illumina sequence processing—Fungi (Flight sampling 1 and 2)
The forward reads were de-multiplexed by using
fastq-multx v. 1.02.772, a tool from ea-utils software pack-
age [88], with the forward amplification primers fungi as
search targets.
The 5′-ends of the sorted reads were trimmed for a pre-
determined length based on the length of the correspond-
ing amplification primer for each dataset. The reads were
further processed to remove all remaining sequences of the
amplification primers and the Illumina TruSeq adapters
from their 3′-ends using consecutively fastq-mcf v.
1.04.807 program [88] for exact sequence search, and agrep
(http://www.tgries.de/agrep/) and treagrep (0.8.0: https://
github.com/laurikari/tre/) programs for search allowing up
to three mismatches between the primers/adapters and the
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primers/adapters were removed, the processed reads exhib-
ited multimodal length distribution. The reads from the
fungal datasets formed three groups of 184–223 bp, 224–
246 bp, and 246–282 bp length. This correlates well with
known length variability of ITS sequences from different
fungal phyla [89]. Each of the three groups was separately
subjected to the OTU clustering and taxonomy assignment
procedures, and the results were merged together for fur-
ther statistical treatment and visualization. ITS1 sequence
clustering and taxonomy assignment were performed using
USEARCH version 8.1.1756 [90]. For each collection of the
related datasets, the OTUs were established by selecting
high-quality reads with an expected error rate not exceed-
ing 0.5%. The selected reads were further de-replicated,
sorted, clustered at the default 3% difference, and
de-chimerized against the UCHIME reference dataset dis-
tributed by UNITE [79]. Then, the reads from individual
samples were filtered to exclude those with the expected
error rate above 6%, and mapped to the OTUs. Taxonomy
was assigned using the Warcup training dataset V1 (http://
drive5.com/utax/data/utax_warcup_trainset1.tar.gz), with a
bootstrap threshold of 50%.
The ITS targeted amplicon sequencing for Flight 3 sam-
ples did not yield any product to move forward in generat-
ing sequences and this might be due to the low fungal
biomass of the samples.Statistical analysis
Bar graphs and strip charts of CFU and qPCR data were
plotted using Prism (GraphPad Software, version 5.0a;
Irvine, CA). Significance (P < 0.05) between groups was
tested with the Kruskal-Wallis test followed by Dunn’s
post-hoc test.Amplicon sequence analysis
Bacterial ASV sequences and Fungal OTUs were sum-
marized to the family and/or genus level using QIIME
[91]. The ALDEx R package version 2 [70] was used to
statistically compare the relative abundances of bacterial
family level taxa between the different flights and
locations based on the expected values of 128 Dirichlet
Monte Carlo instances of centered log ratio (clr) trans-
formed data [71]. A value of zero indicates that organism
abundance was equal to the geometric mean abundance.
Thus, organisms more abundant than the mean would
have positive values, and those less abundant than the
mean would have negative values. Significance was based
on the Benjamini-Hochberg corrected P value of the
Kruskal-Wallis statistical test (significance threshold P <
0.05). ALDEx2 was also used to compare fungal genus
level taxa between flights and differential ASVs and
OTUs between samples and controls.The R script of SourceTracker (version 0.9.1), the con-
tamination predictor tool, was used to assess contamination
of the samples [92]. ISS surface wipes were designated as
sink and the field and Maxwell negative controls as sources.
Samples were rarified to 1000 reads.
QIIME was also used to calculate Shannon’s diversity and
taxa richness. Statistical analysis of Shannon’s diversity and
taxa richness was performed in Prism using the non-para-
metric Kruskal-Wallis test with the Benjamini Hochberg
FDR multiple test correction.
Genus level counts were clr transformed using the “com-
positions” package in R [93] and visualized with a heat-map
created with the “gplot” package in R. Barplots, boxplots,
CCA plots, and pie charts were all created in R.Comparison of ISS environmental microbiome with Earth
microbiome
The ISS environmental microbiome data were proc-
essed by Deblur 1.0.4 [94] trimming at 90 nt with de-
faults except for setting —min-reads 1 to avoid
filtering sequences across samples prior to merging
sample sets. The published Earth Microbiome Project
90 nt BIOM table [27] was obtained from ftp://ftp.
microbo.me. Deblur 1.0.4 90nt BIOM tables of Hos-
pital Microbiome Project (Qiita study 10,172) and Of-
fice Succession Study (Qiita study 10,423) were
obtained from Gonzalez et al. [95] using redbiom
analysis (https://github.com/biocore/redbiom). Only
the reference-hit sOTUs were used across all studies
including ISS microbiome datasets. All studies were
merged using the BIOM Table Python application
programming interface (API). Using the API, sOTUs
with fewer than 25 total observed sequences were fil-
tered as was previously performed [96] and samples
were rarefied to 1000 sequences per sample. The data
were then imported into QIIME2 2018.11 [97] and
unique sOTUs were inserted into Greengenes 13_8
[98] using SEPP [99] via the QIIME2
fragment-insertion plugin [100]. For UniFrac, frag-
ment insertion was performed, which was previously
shown to ameliorate primer biases [100]. Unweighted
UniFrac was computed using Striped UniFrac [101]
through QIIME2’s diversity plugin with –p-bypas-
s-tips, principal coordinates were computed using
FSVD [102] as used elsewhere [101] and the coordi-
nates were visualized using the EMPeror [103] plugin
in QIIME2. Unique sOTUs were assessed in a Jupyter
Notebook [104] using the BIOM Table API.Controls and nomenclature of the samples
Controls were taken in all steps of the study for all
three flight sessions. There was a field control “CTL,”
which was a wipe that was opened to the ISS
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a Maxwell “DNACTL,” which was water that was used
during the DNA extraction steps instead of surface or
control wipe samples and acted as a DNA extraction
reagent control. The field controls were either treated
with PMA (“CTL_P”) or left untreated (“CTL”). In total,
there were ten controls analyzed during bacterial qPCR
and Illumina amplicon sequencing. Likewise, for fungal
analysis, the same controls were collected; however, no
amplicons were generated for “DNACTL” for either flight
nor CTL_P for Flight 1 during qPCR or Illumina library
prep and thus were not sent for amplicon sequencing.
Similarly, for qPCR and Illumina sequencing, required re-
agent controls were tested. The samples during this study
were designated with flight session number followed by
location number (sampling sites). For example, sample
number “F1_3” denotes that surface materials were taken
from the first flight at location 3 but sample was not
treated with PMA, whereas “F1_3P” denotes that same
sample was treated with PMA.
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